Doc328 laid it all out too. There were several missing CDR measures, including one related to POA, Simple Reaction Time. That's frustrating and picking because we would certainly have that since we have the othertwo reaction metrics and it would have enabled a composite POA comparison to Rivastigmine.
8 of the 10 cdr tests were included in the ctad presentation, just not broken down individually. Only tracking and simple reaction time I think maybe weren't included.